Immunotherapy may be better than chemotherapy for Merkel cell carcinoma

The first study of the immunotherapy drug pembrolizumab as the initial treatment for patients with a rare but aggressive form of skin cancer known as Merkel cell carcinoma reports better responses and longer survival than expected with conventional chemotherapy.

Original Article: The Medical News http://bit.ly/2vtn9T2


>>Hollywood's Exotic Secret For Healthy Weight Loss

0 Response to "Immunotherapy may be better than chemotherapy for Merkel cell carcinoma"

Post a Comment